Innoviva Stock Market Value
| INVA Stock | USD 19.05 0.09 0.47% |
| Symbol | Innoviva |
Innoviva Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Innoviva. If investors know Innoviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Innoviva listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.98) | Earnings Share 0.8 | Revenue Per Share 5.6 | Quarterly Revenue Growth 0.331 | Return On Assets 0.0937 |
The market value of Innoviva is measured differently than its book value, which is the value of Innoviva that is recorded on the company's balance sheet. Investors also form their own opinion of Innoviva's value that differs from its market value or its book value, called intrinsic value, which is Innoviva's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innoviva's market value can be influenced by many factors that don't directly affect Innoviva's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innoviva's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innoviva is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innoviva's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Innoviva 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Innoviva's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Innoviva.
| 10/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in Innoviva on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding Innoviva or generate 0.0% return on investment in Innoviva over 30 days. Innoviva is related to or competes with Protalix Biotherapeutics, PDS Biotechnology, Elevation Oncology, Day One, Amylyx Pharmaceuticals, Terns Pharmaceuticals, and Apellis Pharmaceuticals. Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationa... More
Innoviva Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Innoviva's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Innoviva upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.24 | |||
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 6.8 | |||
| Value At Risk | (1.75) | |||
| Potential Upside | 1.59 |
Innoviva Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Innoviva's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Innoviva's standard deviation. In reality, there are many statistical measures that can use Innoviva historical prices to predict the future Innoviva's volatility.| Risk Adjusted Performance | 0.004 | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.18) | |||
| Sortino Ratio | (0.10) | |||
| Treynor Ratio | (0.01) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Innoviva's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Innoviva Backtested Returns
Innoviva holds Efficiency (Sharpe) Ratio of -0.0187, which attests that the entity had a -0.0187% return per unit of risk over the last 3 months. Innoviva exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Innoviva's Risk Adjusted Performance of 0.004, downside deviation of 1.24, and insignificant Market Risk Adjusted Performance to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.59, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Innoviva's returns are expected to increase less than the market. However, during the bear market, the loss of holding Innoviva is expected to be smaller as well. At this point, Innoviva has a negative expected return of -0.0208%. Please make sure to check out Innoviva's sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to decide if Innoviva performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.16 |
Very weak predictability
Innoviva has very weak predictability. Overlapping area represents the amount of predictability between Innoviva time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Innoviva price movement. The serial correlation of 0.16 indicates that over 16.0% of current Innoviva price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.16 | |
| Spearman Rank Test | -0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.09 |
Innoviva lagged returns against current returns
Autocorrelation, which is Innoviva stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Innoviva's stock expected returns. We can calculate the autocorrelation of Innoviva returns to help us make a trade decision. For example, suppose you find that Innoviva has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Innoviva regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Innoviva stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Innoviva stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Innoviva stock over time.
Current vs Lagged Prices |
| Timeline |
Innoviva Lagged Returns
When evaluating Innoviva's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Innoviva stock have on its future price. Innoviva autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Innoviva autocorrelation shows the relationship between Innoviva stock current value and its past values and can show if there is a momentum factor associated with investing in Innoviva.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Innoviva offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Innoviva's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Innoviva Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Innoviva Stock:Check out Innoviva Correlation, Innoviva Volatility and Innoviva Alpha and Beta module to complement your research on Innoviva. For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Innoviva technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.